Pleomorphic liposarcoma of the uterus: Case report and literature review

International Journal of Gynecological Pathology

Volumn 22, Issue 4, 2003, Pages 407-411

  Levine, Pascale Hummel ^a,c   Wei, Xiao Jun ^a   Gagner, Jean Pierre ^a   Flax, Herschel ^b   Mittal, Khush ^a   Blank, Stephanie V ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Pleomorphic liposarcoma; Tamoxifen; Uterus

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CASE REPORT; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LIPOSARCOMA; PLEOMORPHIC LIPOSARCOMA; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TUMOR CELL; UTERUS CANCER;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; LIPOSARCOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TAMOXIFEN; UTERINE NEOPLASMS;

EID: 0141457885     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000092156.33490.89     Document Type: Article

References (29)

1. Veliath AJ, Hannah P, Ratnakar C, et al. Primary liposarcoma of the cervix: A case report. Int J Gynaecol Obstet 1978;16:75-9.
2. Bapat K, Brustein S. Uterine sarcoma with liposarcomatous differentiation: report of a case and review of the literature. Int J Gynecol Obstet 1989;28:71-5.
3. Obafunwa JO, Uguru VE. Liposarcoma of the cervix. Trop Geogr Med 1990;42:90-1.
4. Takeuchi K, Murata K, Funaki K, et al. Liposarcoma of the uterine cervix: case report. Eur J Gynaecol Oncol 2000;21:290-1.
5. Schneebauer J, Brinninger G, Halabi M, et al. Liposarcoma of the uterus. Gynakol Geburtshilfliche Rundsch 1996;36:90-1.
6. Schmidt C, Doroszewski AW. Liposarcoma of the uterus. A case report. Geburtshilfe Frauenheilkd 1996;56:262-4.
7. Enzinger FM, Winslow DJ. Liposarcoma: A study of 103 cases. Virchows Arch Path Anat 1962;335:367-88.
8. Mentzel T, Bosenberg M, Fletcher CDM. Pleomorphic liposarcoma: Clinicopathologic and prognosis analysis of 31 cases [abstract]. Mod Pathol 1999;12:13A.
9. Downes KA, Goldblum JR, Montgomery EA, et al. Pleomorphic liposarcoma: A clinicopathologic analysis of 19 cases. Mod Pathol 2001;14:179-84.
10. Oliveira AM, Nascimento AG. Pleomorphic liposarcoma. Semin Diagn Pathol 2001;18:274-85.
11. Weiss SW, Goldblum JR. Liposarcoma. In Enzinger FM, Weiss SW. Soft Tissue Tumors, 4th ed. St. Louis, MO: Mosby, 2001:641-93.
12. Gebhard S, Coindre JM, Michels JJ, et al. Pleomorphic liposarcoma: Clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases. Am J Surg Pathol 2002;25:601-16.
13. Sieinski W. Lipomatous neometaplasia of the uterus. Report of 11 cases with discussion of histogenesis and pathogenesis. Int J Gynecol Pathol 1999;9:357-63.
14. Hornick JL, Fletcher CD. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 2002;117:188-93.
15. Chaudhuri PK, Walker MJ, Beattie CW, et al. Distribution of steroid hormone receptors in human soft tissue sarcomas. Surgery 1981;90:149-53.
16. Chaudhuri PK, Walker MJ, Beattie CW, et al. The steroid hormone receptors in tumors of adipose tissue. J Surg Oncol 1985;28:87-9.
17. Weiss SW, Langloss JM, Shmookler BM, et al. Estrogen receptor protein in bone and soft tissue tumors. Lab Invest 1986;54:689-94.
18. Sreekantaiah C, Karakousis CP, Leong SP, et al. Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer 1992;69:2484-95.
19. Mertens F, Stromberg U, Mandahl N, et al. Prognostically important chromosomal aberrations in soft tissue sarcomas: A report of the Chromosomes and Morphology (CHAMP) Study Group. Cancer Res 2002;62:3980-4.
20. Fritz B, Schubert F, Wrobel G, et al. Microarray-based copy number expression profiling in dedifferentiated and pleomorphic liposarcoma. Cancer Res 2002;62:2993-8.
21. Den Bakker MA, Hegt VN, Sleddens HB, et al. Malignant mesenchymoma of the uterus, arising in a leiomyoma. Histopathology 2002;40:65-70.
22. McCluggage WG, Abdulkader M, Price JH, et al. Uterine carcinosarcomas in patients receiving tamoxifen. A report of 19 cases. Int J Gynecol Cancer 200;10:280-4.
23. Kloos I, Delaloge S, Pautier P, et al. Tamoxifen-related uterine carcinosarcomas occur under/after prolonged treatment: Report of five cases and review of the literature. Int J Gynecol Cancer 2002; 12:396-400.
24. Wickerham DL, Fisher B, Wolmark N, et al. Association of tamoxifen and uterine sarcoma. J Clin Oncol 2002;20:2758-60.
25. Clement PB, Oliva E, Young RH. Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: A report of six cases and a review of tamoxifen-associated endometrial lesions. Int J Gynecol Pathol 1996;15:222-9.
26. Silva EG, Tornos CS, Follen-Mitchel M. Malignant neoplasms of the uterine corpus in patients treated for breast carcinomas: the effect of Tamoxifen. Int J Gynecol Pathol 1994;13:248-58.
27. Meis JM, Enzinger FM. Myolipoma of soft tissue. Am J Surg Pathol 1991;15:121-5.
28. Michal M. Retroperitoneal myolipoma: a tumor mimicking retroperitoneal angiomyolipoma and liposarcoma with myosarcomatous differentiation. Histopathology 1994;25:86-8.
29. Mentzel T, Fletcher CDM. Dedifferentiated myxoid liposarcoma: A clinicopathological study suggesting a closer relationship between myxoid and well-differentiated liposarcoma. Histopathology 1997;30:457-63.